Progressive Multifocal Leukoencephalopathy Following Combined Rituximab-Based Immune-Chemotherapy for Post-transplant Lymphoproliferative Disorder in a Renal Transplant Recipient: A  Case Report

Transplant recipients are at risk of developing progressive multifocal leukoencephalopathy (PML), an opportunistic infection due to reactivation of JC virus. Post-transplant lymphoproliferative disorders (PTLDs) represent a common malignancy in this population, and antiCD20-therapy has become an established component of its treatment.

Source: Transplantation Proceedings - April 1, 2018 Category: Transplant Surgery Authors: M. Windpessl, S. Burgstaller, A. Kronbichler, H. Pieringer, O. Kalev, A. Karrer, M. Wallner, J. Thaler Tags: Original Contributions: Case Reports Source Type: research